Craig A Clifford DVM, MS, DACVIM (Oncology)
Philip J. Bergman DVM, PhD, DACVIM-Oncology
Course Open: July 22-August 2, 2020
Real Time Sessions (RTS): Wednesday July 29, 2020; 8:00-10:00 pm ET (USA)
Course RTS Times in Your Area: World Clock Converter Level and Prerequisites: This advanced course will be open to veterinarians and veterinary technicians/technologists actively interested in canine liver tumors, particularly hepatocellular carcinomas, and transitional cell carcinoma of the urinary bladder.
VIN CE Course: Open to veterinarians and veterinary technicians/technologists. This course is approved by RACE for veterinarians and veterinary technicians/technologists. (RACE 22-42349 ) Course Information:
This course will go over hepatocellular carcinoma and bladder transitional cell carcinoma: their diagnosis, treatment options, and prognosis. Week 1 (Real Time Session July 29,2020): Intra-Abdominal Neoplasia
Presenters: Dr. Bernard Séguin, Dr. Craig A Clifford, Philip J. Bergman
Objectives: Upon completion of this session, the participant should be able to
- Have a better understanding of the anatomy of the liver
- Primary hepatic tumors will be discussed:
- Tumors types and frequency
- Signalment and clinical signs
- Clinical staging including bloodwork and imaging
- Therapy to include surgical aspects and medical aspects (chemotherapy, radiation therapy, interventional techniques and novel therapies)
- Review surgical techniques to remove hepatic tumors
- Transitional cell carcinoma will be discussed:
- Etiology, signalment, clinical signs
- Staging and diagnosis
- Treatment options to include surgical, medical (NSAIDs, chemotherapy, tyrosine kinase inhibitors), radiation therapy and interventional techniques
Required Textbook(s): There is no required textbook for this course. About the Presenters:
Bernard Seguin obtained his DVM from the University of Montreal. He performed a small animal internship at the University of Illinois and completed a Masters of Science and Small Animal Surgery Residency at Washington State University. He then went on to fulfill his Fellowship in Surgical Oncology at Colorado State University. He was on Faculty at the University of California, Davis, and Oregon State University and is currently a Professor of Surgical Oncology at the Flint Animal Cancer Center, Colorado State University. Dr Seguin is an ACVS Founding Fellow of Surgical Oncology. Dr. Seguin has lectured regionally, nationally, and internationally. He is the author of numerous scientific articles and book chapters. He is the co-editor of the textbook Veterinary Surgical Oncology. Phil Bergman is the Director of Clinical Studies for VCA. He is an adjunct faculty member of the Memorial Sloan-Kettering Cancer Center and the principal veterinary investigator for the canine melanoma vaccine (Oncept®), which was fully licensed in 2009. Prior to Dr. Bergman joining VCA, he served as the Chief Medical Officer for BrightHeart Veterinary Centers from 2007 to 2011; from 1999 – 2007 he was the head of the Donaldson-Atwood Cancer Center at AMC. After finishing veterinary school from Colorado State in 1990, he was an intern at Kansas State (‘90-‘91) and returned to CSU for his medical oncology residency (‘91-‘94) and then completed a PhD Fellowship in human cancer biology from the M.D. Anderson Cancer Center in Houston (‘94-‘99). He was previously Chair of the ACVIM Board of Regents and President of the Veterinary Cancer Society. Craig Clifford is a medical oncologist and the Director of Clinical Studies for Hope Veterinary Specialists in Malvern PA. Dr. Clifford is a well renowned oncologist who has authored/co-authored over 60 papers and book chapters. He is a frequent lecturer at major veterinary meetings in the USA and internationally. Dr. Clifford has served on multiple committees within VCS, ACVIM, VSSO the Oncology Pathology Working Group. He is an advisory board member to both industry and foundation partners. Total CE Credit: 2
Tuition: Member $46 ($41 early bird special if enrolled by July 8, 2020)
Non-Member $110 ($99 early bird special if enrolled by July 8, 2020)
Prices are listed in US dollars. *Enroll in 2 or more Surgical Oncology courses on the same day and receive a 15% discount.
- ONCO112-0720: Intro to Surgical Oncology and Histopathology
- ONCO113-0720: Multimodal Approach to Intra-Abdominal Neoplasia
- ONCO114-0820: Multimodal Approach to Intra-Thoracic Neoplasia
- ONCO115-0820: Multimodal Approach to Mast Cell and Soft Tissue Neoplasia
- Enrollment qualifications: VIN CE courses are open to VIN member and non-member veterinarians. Veterinarians enrolling in a VSPN CE course must be a VIN member. Veterinary support staff must be a VSPN member to enroll in a VSPN CE or a VIN CE course open to VSPN member enrollment.
- Each enrollee must be able to receive emails from @vspn.org and @vin.com addresses. Email is our major form of communication with participants; personal emails are highly recommended rather than clinic/hospital email addresses.
- Each person is individually responsible for his/her own registration. To ensure that all information received is secure and correct, please do not enroll for a course on behalf of another individual.
- For further assistance call 800-846-0028 ext. 797 or email CEonVIN. Please include the course title, your full name, and contact information in your correspondence.
VIN Education Director VIN CE Services: CEonVIN
800-846-0028 or 530-756-4881; ext. 797
or direct line to VIN/VSPN from the United Kingdom: 01 45 222 6154
or direct line to VIN/VSPN from Australia: 02 6145 2357